At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02196 FOSUN PHARMA
Market Closed 10-23 16:08:09
16.490
+0.220
+1.35%
High16.540
Low15.980
Vol2.80M
Open16.270
D1 Closing16.270
Amplitude3.44%
Mkt Cap43.67B
Tradable Cap8.74B
Total Shares2.65B
T/O45.57M
T/O Rate0.53%
Tradable Shares530.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
AriBio Secures KRW42.5 Billion Investment From Fosun Pharma
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a China-based company principally engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company operates its businesses through five segments. The Pharmaceuticals segment is primarily engaged in the research, development, production and sales of pharmaceuticals. The Medical Devices and Diagnostics segment is primarily engaged in the research, development, production and sales of medical devices and diagnostic products. The Healthcare Services segment is primarily engaged in the provision of healthcare services and hospital management. The Pharmaceutical Distribution and Retail segment primarily engages in the distribution and retail of pharmaceuticals and medical devices. The Company also operates the Other segment. The Company mainly operates its businesses in the domestic market and overseas markets.